tradingkey.logo

Bioventus Inc

BVS
查看详细走势图
8.510USD
+0.300+3.65%
收盘 02/06, 16:00美东报价延迟15分钟
569.95M总市值
54.31市盈率 TTM

Bioventus Inc

8.510
+0.300+3.65%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.65%

5天

+7.31%

1月

+11.83%

6月

+22.80%

今年开始到现在

+14.38%

1年

-19.26%

查看详细走势图

TradingKey Bioventus Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Bioventus Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名13/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价15.00。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bioventus Inc评分

相关信息

行业排名
13 / 205
全市场排名
84 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

Bioventus Inc亮点

亮点风险
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
估值高估
公司最新PE估值54.31,处于3年历史高位
机构减仓
最新机构持股49.87M股,环比减少0.00%
HACAX持仓
明星投资者HACAX持仓,最新持仓市值19.50K
活跃度增加
近期活跃度增加,过去20天平均换手率0.49

分析师目标

根据 3 位分析师
买入
评级
15.000
目标均价
+85.19%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Bioventus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bioventus Inc简介

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
公司代码BVS
公司Bioventus Inc
CEOClaypoole (Robert E)
网址https://www.bioventus.com/
KeyAI